Module 8 Flashcards

complement

1
Q

opsonins

A

play an important role in defence and inflammation
- they coat foreign particles to tag or mark them for engulfment by APCs
- opsonized bacteria is easily phagocytosed by the macrophage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

discovery of complement

A

1896, Jules Bordet discovered complement protein through studies of cholera. he discovered complement proteins that exist in the blood by heating serum
- in his findings, the antibody (heat stable) was responsible for immunity against specific microorganisms
- the complement proteins (heat sensitive) was responsible for non-specific antimicrobial activity conferred by all normal serum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

complement proteins

A

enhance the killing of bacteria by binding to bacteria-bound antibodies
- these proteins are heat labile, meaning they lose their effector activity is heated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

primary sources of complement

A

monocytes, macrophages, and hepatocytes are the primary synthetic sources of glycoprotein (complement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

activation pathways

A

classical pathway
alternative pathway
lectin pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

regulation pathways

A

glycoproteins regulate complement activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

complement activation

A

can be divided into 2 components:
- in the first component, there are 3 distinct pathways that can result in the production of C5b proteins
- the pathways converge to result in inflammation, opsonization, and lysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

classical pathway

A

Ag:Ab complexes
classical pathway requires antibodies and is activated by immune complexes (Ab:Ag) involving human IgM, IgG1, IgG2, and IgG3
- IgG4 is NOT a complement activator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

lectin pathway

A

pathogen surfaces
an antibody independent process that is activated by mannan, which is expressed only on bacteria and viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

alternative pathway

A

pathogen surfaces
activated by non-Ab substances, such as LPS, polymers, or venom factors
- these substances can originate from pathogens or human IgA and IgG aggregates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

classical pathway step 1

A

antibodies bind to a multivalent antigen on the cell membrane of the target cell
- the C1 complex then binds to the Fc portion of the antibody bound to the target cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

C1 complex

A

C1qr2s2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

classical pathway step 2

A

inactivate circulating C4 binds to the C1q portion of the Ig-associated C1 complex the r2s2 enzymes then cleaves C4 into C4a and C4b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

classical pathway step 3

A

C4b covalently attaches to cell membrane or antibody
- C2 binds to C4b
- C1qr2s2 cleaves C2 into C2a and C2b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

classical pathway step 4

A

C4b and C2a combine to form C3 convertase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

C3 convertase

A

C4bC2a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

classical pathway step 5

A

C3 convertase binds to and cleaves C3 into C3a and C3b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

classical pathway step 6

A

C3b molecule binds to C4bC2a to form C5 convertase
- unbound C3b can either by hydrolyzed (becomes inactive) or form covalent bonds with target cell surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

classical pathway step 7

A

C5 convertase binds to C5 and cleaves it into C5b
- C5b is the end product that all 3 complement pathways create

20
Q

lectin pathway step 1

A

serum mannose-binding lectin (MBL) binds to mannose residues on glycoproteins or carbohydrates on microbe surface
- MBL is an acute phase protein produced during inflammation

21
Q

lectin pathway step 2

A

MBL-associated serine protease (MASP) binds to MBL

22
Q

lectin pathway step 3

A

the active MASP-MBL complex cleaves inactive C4 into active C4b and C4a

23
Q

lectin pathway step 4

A

C4b can covalently attach to the pathogen cell membrane via mannose binding. following this, C2 binds to C4b

24
Q

lectin pathway step 5

A

C2 of the C4bC2 complex is cleaved by MASP to form C4bC2a (C3 convertase)

25
Q

lectin pathway step 6

A

C3 convertase binds to and cleaves C3 into C3b and C3a

26
Q

lectin pathway step 7

A

C3b molecules bind to C4bC2a to form C5 convertase
- unbound C3b can either by hydrolyzed (inactivated) or it can form covalent bonds with target cell surfaces

27
Q

lectin pathway step 8

A

C5 convertase binds to C5 and cleaves it into C5b
- C5b is the end protein of the three complement pathways

28
Q

alternate pathway step 1

A

in the plasma, a continuously low rate of spontaneous cleavage of C3 occurs
- this cleavage results in C3a and C3b

29
Q

internal thioester bonds of C3

A

intact C3 has a concealed thioester group
- during C3 cleavage, the C3 alpha chain is cleaved by C3 convertase, leaving the thioester group exposed in C3b, which can result in two different things

30
Q

two fates of C3b thioester bond

A
  1. in fluid phase, C3b is inactivated by hydrolysis
  2. covalent attachment of C3b to microbe, cell surface protein, or polysaccharide by thioester linkage
31
Q

alternative pathway step 2

A

some C3b binds to the microbial cell surface via active thioester bond
- from here, factor B binds to C3b

32
Q

alternative pathway step 3

A

factor D cleaves Factor B (which is still bound to C3b)

33
Q

alternative pathway step 4

A

properdin, or Factor P, stabilizes the C3bBb complex
- stabilized C3bBb complex is called C3 convertase

34
Q

alternative pathway step 5

A

there is cleavage of an additional C3 molecules by C3 convertase

35
Q

alternative pathway step 6

A

binding of the additional C3b to the cell surface forms C3bBbC3b complex called C5 convertase

36
Q

alternative pathway step 7

A

C5 convertase cleaves C5 into C5b
- C5b is the end product

37
Q

activators of each pathway

A

Classical: Ag-Ab complex
Lectin: MBL:mannose complex
Alternative: spontaneous hydrolysis of C3

38
Q

C3 convertase in each pathway

A

C: C4bC2a
L: C4bC2a
A: C3bBb

39
Q

C5 convertase of each pathway

A

C: C4bC2aC3b
L: C4bC2aC3b
A: C3bBbC3b

40
Q

late steps of complement activation

A

the 3 complement activation pathways converge at C5b. late steps of complement activation forms the membrane attack complex (MAC), which will form a pore in the target cell membrane, leading to its destruction

41
Q

complement activation outcomes

A

inflammation
opsonization
lysis

42
Q

complement cascade formation of MAC

A
  1. C5 convertase cleaves C5 into C5a and C5b. C5b remains bound to C5 convertase
  2. C6 and C7 sequentially bind to C5b. C5bC6C7 complex becomes directly inserted into the lipid bilayer of the target cell membrane 3. after insertion of the C5bC6C7, C8 is bound to C7 to stabilize the complex 4. up to 15 C9 molecules polymerize around the C5bC6C7C8 complex to form the MAC
43
Q

MAC attack

A

MAC creates pores in the cell membrane, and each pore is made of the C9 proteins - a pore in the membrane results in the spilling of intracellular contents, initiating cell death (MAC attack)

44
Q

regulation of complement activation

A

complement activation is continuously occurring at a low level and can result in normal cell damage if not regulated
- fragmented complement proteins can diffuse to adjacent cells and injure them
complement activation is inhibited by regulatory proteins that are present on normal host cells, but are absent on microbes
- types of regulation: C1 complex inhibition, C3 Convertase inhibition, C3b inactivation, MAC inhibition

45
Q

C1 inhibitor deficiency

A

causes HAE
- HAE results in the overproduction of C2b by activating the vasoactive C2 kinin peptide in the presence of plasmin
- HAE results in edema of skin

46
Q

complement deficiencies

A

can have detrimental effects on immunity
can be caused by a partial or complete loss of protein synthesis (ex: minimal to absent C3)
deficiencies can also be caused by formation of an incomplete or abnormal protein

47
Q

complement deficiency diseases

A

C1, C2, and C4 deficiency: immune complex disease

MAC deficiency: increased risk of infection

C3, Factor D, Factor I deficiency: pyogenic infections

MBL deficiency: susceptible to recurrent infections and decreased lung function